Viscerotropic potential of parasites isolated from post-kala-azar dermal leishmaniasis cases : An experimental evidence

Viscerotropic potential of parasites isolated from post-kala-azar dermal leishmaniasis cases : An experimental evidence

Bibliographic Details
Main Author:	A.K. Gupta, S. Narayan, N. Verma, A.K. Thakur & P. Das
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2012-12-01
Series:	Journal of Vector Borne Diseases
Subjects:	India Leishmania donovani leishmaniasis viscerotropism
Online Access:	http://www.mrcindia.org/journal/issues/494266.pdf

Similar Items

Post kala-azar dermal leishmaniasis: Clinical features and differential diagnosis
by: Piyush Kumar, et al.
Published: (2021-01-01)

Kala-azar in a Brazilian child
by: Michael K. Hole, et al.
Published: (2011-04-01)

Kala-azar Control, Uganda
by: Jan H. Kolaczinski, et al.
Published: (2007-03-01)

Kala-azar Epidemiology and Control, Southern Sudan
by: Jan H. Kolaczinski, et al.
Published: (2008-04-01)

Kala-azar and Post–Kala-azar Dermal Leishmaniasis, Assam, India
by: Abdul Mabood Khan, et al.
Published: (2014-03-01)

Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report
by: José Angelo Lauletta Lindoso, et al.

Role of IL-17 gene polymorphism in Indian kala-azar
by: R Khatonier, et al.
Published: (2020-01-01)

Epidemiology of post-kala-azar dermal leishmaniasis
by: Pramit Ghosh, et al.
Published: (2021-01-01)

Low prevalence of <it>Leishmania donovani</it> infection among the blood donors in kala-azar endemic areas of Bangladesh
by: Huda M Mamun, et al.
Published: (2013-02-01)

Post-kala-azar dermal Leishmaniasis in two different clinical contexts
by: Daniel Holanda Barroso, et al.
Published: (2015-06-01)

Leptomonas seymouri Co-infection in Cutaneous Leishmaniasis Cases Caused by Leishmania donovani From Himachal Pradesh, India
by: Lovlesh Thakur, et al.
Published: (2020-07-01)

Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi
by: M. P. Oliveira Neto, et al.
Published: (1986-09-01)

Atypical post kala azar dermal leishmaniasis with ′′Muzzle area′′ swelling
by: Sandeep Arora, et al.
Published: (2015-01-01)

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Bittencourt Achiléa, et al.
Published: (2003-01-01)

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Bittencourt Achiléa, et al.
Published: (2002-01-01)

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Achiléa Bittencourt, et al.

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Achiléa Bittencourt, et al.

Visceral Leishmaniasis, Northern Somalia, 2013–2019
by: Mikko K. Aalto, et al.
Published: (2020-01-01)

The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India
by: Neeloo Singh, et al.
Published: (2014-12-01)

Pediatric lymphatic leishmaniasis: a case report
by: Endeshaw Asaye Kindie, et al.
Published: (2023-04-01)

Clinical and epidemiological characteristics of cutaneous leishmaniasis in Sri Lanka
by: Devika Iddawela, et al.
Published: (2018-03-01)

Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease
by: Bruno Mendes Roatt, et al.
Published: (2014-06-01)

Immune responses in post kala-azar dermal leishmaniasis
by: Mitali Chatterjee, et al.
Published: (2020-01-01)

Parasite load and its association with disease outcome in cutaneous leishmaniasis in Sri Lanka
by: F. H. Riyal, et al.
Published: (2021-04-01)

Comparative Proteomic Profiling of Leishmania tropica: Investigation of a Case Infected with Simultaneous Cutaneous and Viscerotropic Leishmaniasis by 2-Dimentional Electrophoresis and Mass Spectrometry
by: Homa HAJJARAN, et al.
Published: (2015-10-01)

Comparative Genomic Analyses of New and Old World Viscerotropic Leishmanine Parasites: Further Insights into the Origins of Visceral Leishmaniasis Agents
by: Fernando Tobias Silveira, et al.
Published: (2022-12-01)

The FML (Fucose Mannose Ligand) of Leishmania donovani: a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar
by: Claris B. Palatnik de Sousa, et al.
Published: (1996-04-01)

Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013-01-01)

Leishmania donovani Infection with Atypical Cutaneous Manifestations, Himachal Pradesh, India, 2014–2018
by: Lovlesh Thakur, et al.
Published: (2020-08-01)

Current Perspectives on Leishmaniasis
by: KR Reddy
Published: (2019-02-01)

Is leishmaniasis in Sri Lanka benign and be ignored?
by: N.D. Karunaweera, et al.
Published: (2009-02-01)

Oral amodiaquine microparticles repurposed for the treatment of visceral leishmaniasis
by: Henry Nettey, et al.
Published: (2022-09-01)

Primary laryngeal leishmaniasis: A rare case report
by: Kumar Bipin, et al.
Published: (2009-01-01)

Histopathology of post kala-azar dermal leishmaniasis
by: V Ramesh, et al.
Published: (2020-01-01)

First report of cutaneous leishmaniasis caused by Leishmania donovani in Ethiopia
by: Gashaw Azanaw Amare, et al.
Published: (2023-12-01)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
by: Greta Volpedo, et al.
Published: (2021-06-01)

Indirect Fluorescent antibody test for serodiagnosis of visceral leishmaniasis: An epidemiological study in Iraq.
by: Souhaila Ali, et al.
Published: (2012-06-01)

Visceral leishmaniasis: An immunological viewpoint on asymptomatic infections and post kala azar dermal leishmaniasis
by: Neeraj Tiwari, et al.
Published: (2018-01-01)

Changing clinico-epidemiology of post-kala-azar dermal leishmaniasis (PKDL) in India: Results of a survey in four endemic states
by: Suman Saurabh, et al.
Published: (2020-01-01)

Post kala azar dermal leishmaniasis in a castleman disease patient
by: parichehr kafaie, et al.
Published: (2014-08-01)